Lobby organisation
BioNTech SE
Business / industry · Health & pharma · HQ: Germany · Transparency Register entry
As of 9 September 2026, BioNTech SE appears in 3 declared MEP meetings (3 different MEPs), most often with Socialists & Democrats.
In their own words
“Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies,…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2024. Bar length is relative to its busiest year (2 in 2023).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 16 Jan 2024 | Tomislav Sokol | Pharmaceutical legislation |
| 30 Oct 2023 | Laura Ballarín Cereza | Pharmaceutical Package (Directive) |
| 18 Oct 2023 | Tiemo Wölken | Pharma Revision - Directive (staff level) |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.